PMID: 14421526Mar 1, 1960Paper

The effect of iproniazid and imipramine on the blood platelet 5-hydroxytrptamine level in man

British Journal of Pharmacology and Chemotherapy
E F MARSHALLA TODRICK

Abstract

Observations are reported on the blood platelet 5-hydroxytryptamine content of six patients receiving imipramine, N-(gamma-dimethylaminopropyl)-iminodibenzyl hydrochloride. The response was a fall to a level of one-sixth of the original in three weeks, with little change thereafter. This is in sharp contrast to the action of iproniazid which caused a rise of some 200% in the blood platelet 5-hydroxytryptamine level over the same period. Imipramine in a concentration of 1 mg./ml. had no inhibitory action on 5-hydroxytryptophan decarboxylase; 8.0 mug./ml. of imipramine suppressed two-thirds of the in vitro uptake of 5-hydroxytryptamine (2.5 mug./ml.) by normal human platelets.

References

Jan 1, 1952·Przegla̧d lekarski·J SUPNIEWSKI
Nov 18, 1955·Science·S UDENFRIENDH WEISSBACH
Dec 29, 1955·The Journal of Physiology·R M HARDISTY, R S STACEY
Oct 30, 1957·The Journal of Physiology·J ARMIN, R T GRANT
Mar 1, 1958·British Journal of Pharmacology and Chemotherapy·G V BORNR S STACEY
Nov 1, 1958·The American Journal of Psychiatry·R KUHN
Feb 1, 1959·The American Journal of Psychiatry·H E HIMWICH
Sep 1, 1959·British Journal of Pharmacology and Chemotherapy·P B BRADLEY, B J KEY
Jul 1, 1959·The Journal of Nervous and Mental Disease·A FELDSTEINH FREEMAN

❮ Previous
Next ❯

Citations

Oct 5, 1962·Psychopharmacologia·M G GELDER, J R VANE
May 27, 1974·Naunyn-Schmiedeberg's Archives of Pharmacology·M SorimachiA Inouye
Jan 1, 1973·Naunyn-Schmiedeberg's Archives of Pharmacology·F F De Clerck, R S Reneman
Apr 30, 1973·Naunyn-Schmiedeberg's Archives of Pharmacology·L Ahtee, I Kääriäinen
Oct 15, 1960·Experientia·E COSTAL VALZELLI
Nov 1, 1978·European Journal of Pharmacology·E N PetersenL Wetterberg
Jan 1, 1986·Journal of Psychiatric Research·D HealyB E Leonard
Jan 1, 1990·Progress in Neuro-psychopharmacology & Biological Psychiatry·S P TyrerH W Griffiths
Jan 1, 1973·Progress in Neurobiology·J M Sneddon
Jan 1, 1980·Progress in Neuro-psychopharmacology·C Q MountjoyM Roth
Jan 1, 1993·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M A Barradas, D P Mikhailidis
Feb 1, 1963·British Journal of Pharmacology and Chemotherapy·S J CORNEB T WARNER
Oct 1, 1964·British Journal of Pharmacology and Chemotherapy·M DAY, A STOCKBRIDGE
Jan 1, 1968·British Journal of Pharmacology and Chemotherapy·A Pletscher
Oct 1, 1973·British Journal of Pharmacology·I C Campbell, A Todrick
Aug 1, 1972·Acta Physiologica Scandinavica·M Frisk-Holmberg
Jan 1, 1985·Gastroenterology·G M AndersonD J Cohen
Aug 1, 1962·British Journal of Pharmacology and Chemotherapy·G W ASHCROFT, D F SHARMAN
Jun 1, 1961·British Journal of Pharmacology and Chemotherapy·R S Stacey
Jan 13, 2006·British Journal of Pharmacology·A Richard Green
Nov 1, 1987·Journal of Child Psychology and Psychiatry, and Allied Disciplines·G M AndersonJ G Young
Apr 13, 1968·Nature·H R Baumgartner, G V Born
Jan 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·I C Campbell
May 29, 2009·The European Journal of Neuroscience·H-P Landolt, R Wehrle
Sep 3, 1964·The New England Journal of Medicine·J J KLEINR R WARNER

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.